Neurocysticercosis (NCC) is a parasitic infection caused by Cysticercus cellulosae, the metacestode of pork tapeworm (Taenia solium). NCC is one of the most common public health problems worldwide. We present a patient harboring a bilobed ring-enhancing lesion with a presumed diagnosis of brain metastasis, who returned to the USA after traveling to an endemic region. The diagnosis of NCC was established based on a characteristic resonance of succinate on proton magnetic resonance spectroscopy. Also, higher mean diffusivity and lower fractional anisotropy along with relative cerebral blood volume were observed from the lesion compared to contralateral normal brain regions. Multiparametric analysis may improve the differential diagnosis of ring-enhancing intracranial lesions such as NCC.
MendlovicFFleuryAFlisserA.Zoonotic Taenia infections with focus on cysticercosis due to Taenia solium in swine and humans. Res Vet Sci2021; 134: 69–77.
2.
GarciaHHCastilloYGonzalesI, et al. Low sensitivity and frequent cross-reactions in commercially available antibody detection ELISA assays for Taenia solium cysticercosis. Trop Med Int Health2018; 23: 101–105.
3.
SerpaJAGravissEAKassJS, et al. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore)2011; 90: 81–86.
4.
BurneoJGPlenerIGarciaHH.Neurocysticercosis in a patient in Canada. Can Med Assoc J2009; 180: 639–642.
5.
EsquivelADiaz-OteroFGimenez-RoldanS.Growing frequency of neurocysticercosis in Madrid (Spain). Neurologia2005; 20: 116–120.
6.
GarciaHHGonzalezAEGilmanRH.Taenia solium cysticercosis and its impact in neurological disease. Clin Microbiol Rev2020; 33.
7.
DuqueKRBurneoJG.Clinical presentation of neurocysticercosis-related epilepsy. Epilepsy Behav2017; 76: 151–157.
8.
Del BruttoOH.Neurocysticercosis: a review. Sci World J2012; 2012: 159821.
9.
RamachandranPSWilsonMR.Diagnostic testing of neurologic infections. Neurol Clin2018; 36: 687–703.
10.
Del BruttoOHRajshekharVWhiteACJr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology2001; 57: 177–183.
11.
LernerAShiroishiMSZeeCS, et al. Imaging of neurocysticercosis. Neuroimaging Clin N Am2012; 22: 659–676.
12.
ChawlaSGuptaRKKumarR, et al. Demonstration of scolex in calcified cysticercus lesion using gradient echo with or without corrected phase imaging and its clinical implications. Clin Radiol2002; 57: 826–834.
13.
SainiJGuptaPKGuptaP, et al. 3D-double-inversion recovery detects perilesional gliosis better than 3D-FLAIR and postcontrast T1 imaging in calcified neurocysticercosis. Neurol India2019; 67: 136–141.
14.
ChawlaSHusainNKumarS, et al. Correlative MR imaging and histopathology in porcine neurocysticercosis. J Magn Reson Imaging2004; 20: 208–215.
15.
Abdel RazekAAWatcharakornACastilloM.Parasitic diseases of the central nervous system. Neuroimaging Clin N Am2011; 21: 815–841.
GuptaRKTrivediRAwasthiR, et al. Understanding changes in DTI metrics in patients with different stages of neurocysticercosis. Magn Reson Imaging2012; 30: 104–111.
19.
ChawlaSGuptaRKHusainN, et al. Prediction of viability of porcine neurocysticercosis with proton magnetic resonance spectroscopy: correlation with histopathology. Life Sci2004; 74: 1081–1092.
20.
MishraAMGuptaRKJaggiRS, et al. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr2004; 28: 540–547.
21.
RaffinLSBacheschiLAMachadoLR, et al. Diffusion-weighted MR imaging of cystic lesions of neurocysticercosis: a preliminary study. Arq Neuropsiquiatr2001; 59: 839–842.
22.
GuptaRKPrakashMMishraAM, et al. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas – a report of more than 100 lesions. Eur J Radiol2005; 55: 384–392.
23.
GhoshRNVyasSSinghP, et al. Perfusion magnetic resonance imaging in differentiation of neurocysticercosis and tuberculoma. Neuroradiology2019; 61: 257–263.
24.
GuptaRKAwasthiRGargRK, et al. T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression. Am J Neuroradiol2013; 34: 997–1003.
25.
ChawlaSLeeSCMohanS, et al. Lack of choline elevation on proton magnetic resonance spectroscopy in grade I–III gliomas. Neuroradiol J2019; 32: 250–258.
26.
WangSKimSChawlaS, et al. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage2009; 44: 653–660.
27.
ChawlaSWangSMohanS, et al. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI. J Magn Reson Imaging2019; 49: 184–194.
28.
GarcíaHHDel BruttoOH.Imaging findings in neurocysticercosis. Acta Trop2003; 87: 71–78.
29.
Del BruttoOHNashTEWhiteACJr, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci2017; 372: 202–210.
30.
ShardaDChawlaSGuptaRK.Imaging and spectroscopy of neurocysticercosis. In: SinghGPrabhakarS (eds) Taenia solium cysticercosis from basic to clinical science. Oxon, UK: CAB International, 2002, pp.311–327.
31.
ChawlaSKumarSGargM, et al. Metabolite pattern of cysticercus cellulosae metacestode from different predilection sites of swine using proton magnetic resonance spectroscopy. Parasite2004; 11: 161–167.
32.
AgarwalMChawlaSHusainN, et al. Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in-vivo proton MR spectroscopy. Neuroradiology2004; 46: 211–215.
33.
ChangKHSongICKimSH, et al. In vivo single-voxel proton MR spectroscopy in intracranial cystic masses. Am J Neuroradiol1998; 19: 401–405.
34.
BrandãoLACastilloM.Adult brain tumors: clinical applications of magnetic resonance spectroscopy. Magn Reson Imaging Clin N Am2016; 24: 781–809.
35.
Del Arenal MenaIPBonillaACMoreno-SánchezR, et al. A method for the isolation of tegument syncytium mitochondria from Taenia crassiceps cysticerci and partial characterization of their aerobic metabolism. J Parasitol1998; 84: 461–468.
36.
McManusDPBowlesJ.Molecular genetic approaches to parasite identification: their value in diagnostic parasitology and systematics. Int J Parasitol1996; 26: 687–704.
37.
GargMGuptaRKHusainM, et al. Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology2004; 230: 519–527.
38.
NathKAgarwalMRamolaM, et al. Role of diffusion tensor imaging metrics and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging2009; 27: 198–206.
39.
Shukla-DaveAGuptaRKRoyR, et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging2001; 19: 103–110.
40.
PoptaniHGuptaRKJainVK, et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging1995; 13: 1019–1029.
41.
SantosGTLeiteCCMachadoLR, et al. Reduced diffusion in neurocysticercosis: circumstances of appearance and possible natural history implications. Am J Neuroradiol2013; 34: 310–316.
42.
GuptaRKAwasthiRGargRK, et al. T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression. Am J Neuroradiol2013; 34: 997–1003.
43.
ParryAHWaniAHShaheenFA, et al. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI). Br J Radiol2018; 91: 20180342.
44.
HarisMHusainNSinghA, et al. Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas. J Magn Reson Imaging2008; 28: 588–597.
45.
ChanJHTsuiEYChauLF, et al. Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph2002; 26: 19–23.
46.
PriceSJGreenHADeanAF, et al. Correlation of MR relative cerebral blood volume measurements with cellular density and proliferation in high-grade gliomas: an image-guided biopsy study. Am J Neuroradiol2011; 32: 501–506.
47.
ChiangICHsiehTJChiuML, et al. Distinction between pyogenic brain abscess and necrotic brain tumour using 3-Tesla MR spectroscopy, diffusion and perfusion imaging. Br J Radiol2009; 82: 813–820.
48.
MuccioCFEspositoGBartoliniA, et al. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med2008; 113: 747–757.
49.
BattaAMaheshKVPrabhatN, et al. Newer magnetic resonance imaging techniques in neurocysticercosis. Neuroradiol J2020; 33: 538–544.
50.
SoniNSrindharanKKumarS, et al. Arterial spin labeling perfusion: prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions. Neuroradiol J2018; 31: 544–553.
51.
GarcíaHHDel BruttoOH.Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology1999; 53: 1582–1584.
52.
GilmanRHDel BruttoOHGarcíaHH, et al. Prevalence of Taeniosis among patients with neurocysticercosis is related to severity of infection. The Cysticercosis Working Group in Perú. Neurology2000; 55: 1062.
